Barclays
NUVB.WS

Barclays’s Nuvation Bio Inc Warrants NUVB.WS Stock Holding History

Barclays’s Portfolio NUVB.WS Stock Details NUVB.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,638
Closed -$541 – 5310
2025
Q4 		$541 Hold
1,638
– – ﹤0.01% 5093
2025
Q3 		$331 Hold
1,638
– – ﹤0.01% 5221
2025
Q2 		$442 Hold
1,638
– – ﹤0.01% 5079
2025
Q1 		$410 Hold
1,638
– – ﹤0.01% 5092
2024
Q4 		$377 Hold
1,638
– – ﹤0.01% 5164
2024
Q3 		$160 Hold
1,638
– – ﹤0.01% 5172
2024
Q2 		$262 Hold
1,638
– – ﹤0.01% 4729
2024
Q1 		$495 Hold
1,638
– – ﹤0.01% 4963
2023
Q4 		$98 Hold
1,638
– – ﹤0.01% 5169
2023
Q3 		$164 Hold
1,638
– – ﹤0.01% 4535
2023
Q2 		$271 Hold
1,638
– – ﹤0.01% 4410
2023
Q1 		$197 Hold
1,638
– – ﹤0.01% 4980
2022
Q4 		$237 Sell
1,638
-280
-15% -$37 ﹤0.01% 5175
2022
Q3 		$0 Hold
1,918
– – ﹤0.01% 5034
2022
Q2 		$1K Hold
1,918
– – ﹤0.01% 4942
2022
Q1 		$1K Buy
+1,918
New +$1.93K ﹤0.01% 4845

Barclays's NUVB.WS Position: Q1 2026 in Review

Barclays sold out of Nuvation Bio Inc Warrants (NUVB.WS) in Q1 2026, closing a stake of 1,638 shares — an estimated $541 sold.

Barclays first reported a position in NUVB.WS in Q1 2022 and held it in 16 quarters. The position peaked at $1K in Q2 2022. 0 funds tracked by Wall St. Rank hold NUVB.WS as of Q1 2026.

  • Barclays reported no remaining Nuvation Bio Inc Warrants position as of Q1 2026 after selling out during the quarter.
  • Barclays sold 1,638 Nuvation Bio Inc Warrants shares in Q1 2026, an estimated $541.
  • Barclays first reported a position in Nuvation Bio Inc Warrants in Q1 2022 and held it in 16 quarters.
  • Barclays's Nuvation Bio Inc Warrants position peaked at $1K in Q2 2022.
  • 0 funds tracked by Wall St. Rank held Nuvation Bio Inc Warrants as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.